Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk
Clinical trial NCT02945033 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02945033
- Sponsor
- University Hospital, Rouen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2028-07-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.